Study Title: A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer: Big Ten Cancer Research Consortium. BTCRC-LUN17-127
- Open to Accrual at:
- Closed to Accrual at:
- Learn more:
- Publications and Presentations:
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Subscribe to the Big Ten CRC Newsletter
Twitter
Facebook
YouTube